CD4 T cells specific for a latency-associated γ-herpesvirus epitope are polyfunctional and cytotoxic

Journal of Immunology

Volumn 193, Issue 12, 2014, Pages 5827-5834

  Freeman, Michael L ^a,d   Burkum, Claire E ^a   Cookenham, Tres ^a   Roberts, Alan D ^a   Lanzer, Kathleen G ^a   Huston, Gail E ^a   Jensen, Meghan K ^a   Sidney, John ^b   Peters, Bjoern ^b   Kohlmeier, Jacob E ^a,e   Woodland, David L ^a,f   Van Dyk, Linda F ^c   Sette, Alessandro ^b   Blackman, Marcia A ^a  

^a TRUDEAU INSTITUTE   (United States)

^b LA JOLLA INSTITUTE FOR ALLERGY AND IMMUNOLOGY   (United States)

^c UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

^d CASE WESTERN RESERVE UNIVERSITY   (United States)

^e EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^f Keystone Symposia   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EPITOPE; GAMMA INTERFERON; INTERLEUKIN 2; LYSOSOME ASSOCIATED MEMBRANE PROTEIN 1; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; PROTEIN M2; TUMOR NECROSIS FACTOR ALPHA; CYTOKINE; PEPTIDE; T LYMPHOCYTE RECEPTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CD4+ T LYMPHOCYTE; CELL MEDIATED CYTOTOXICITY; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOLYSIS; CYTOTOXIC T LYMPHOCYTE; GAMMAHERPESVIRINAE; HERPES VIRUS INFECTION; LATENT VIRUS INFECTION; LYMPHOCYTE PROLIFERATION; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; VIRUS LATENCY; AMINO ACID SEQUENCE; ANIMAL; BIOSYNTHESIS; CHEMISTRY; CYTOTOXICITY; IMMUNOLOGY; LYMPHOCYTE ACTIVATION; METABOLISM; MOLECULAR GENETICS; VIROLOGY;

AMINO ACID SEQUENCE; ANIMALS; CD4-POSITIVE T-LYMPHOCYTES; CYTOKINES; CYTOTOXICITY, IMMUNOLOGIC; EPITOPES, T-LYMPHOCYTE; GAMMAHERPESVIRINAE; HERPESVIRIDAE INFECTIONS; INTERFERON-GAMMA; LYMPHOCYTE ACTIVATION; MICE; MOLECULAR SEQUENCE DATA; PEPTIDES; T-CELL ANTIGEN RECEPTOR SPECIFICITY; VIRUS LATENCY;

EID: 84916920214     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1302060     Document Type: Article

References (43)

1. Stevenson, P. G., S. Efstathiou, P. C. Doherty, and P. J. Lehner. 2000. Inhibition of MHC class I-restricted antigen presentation by gamma 2-herpesviruses. Proc. Natl. Acad. Sci. USA 97: 8455-8460.
2. Blackman, M. A., E. Flaño, E. Usherwood, and D. L. Woodland. 2000. Murine gamma-herpesvirus-68: a mouse model for infectious mononucleosis? Mol. Med. Today 6: 488-490.
3. Martorelli, D., E. Muraro, A. Merlo, R. Turrini, A. Rosato, and R. Dolcetti. 2010. Role of CD4+ cytotoxic T lymphocytes in the control of viral diseases and cancer. Int. Rev. Immunol. 29: 371-402.
4. Paludan, C., and C. Münz. 2003. CD4+ T cell responses in the immune control against latent infection by Epstein-Barr virus. Curr. Mol. Med. 3: 341-347.
5. Heller, K. N., F. Arrey, P. Steinherz, C. Portlock, A. Chadburn, K. Kelly, and C. Münz. 2008. Patients with Epstein Barr virus-positive lymphomas have decreased CD4(+) T-cell responses to the viral nuclear antigen 1. Int. J. Cancer 123: 2824-2831.
6. Jia, Q., M. L. Freeman, E. J. Yager, I. McHardy, L. Tong, D. Martinez-Guzman, T. Rickabaugh, S. Hwang, M. A. Blackman, R. Sun, and T. T. Wu. 2010. Induction of protective immunity against murine gammaherpesvirus 68 infection in the absence of viral latency. J. Virol. 84: 2453-2465.
7. Wang, P., J. Sidney, C. Dow, B. Mothé, A. Sette, and B. Peters. 2008. A systematic assessment of MHC class II peptide binding predictions and evaluation of a consensus approach. PLOS Comput. Biol. 4: e1000048.
8. Bui, H. H., J. Sidney, B. Peters, M. Sathiamurthy, A. Sinichi, K. A. Purton, B. R. Mothé, F. V. Chisari, D. I. Watkins, and A. Sette. 2005. Automated generation and evaluation of specific MHC binding predictive tools: ARB matrix applications. Immunogenetics 57: 304-314.
9. Nielsen, M., C. Lundegaard, and O. Lund. 2007. Prediction of MHC class II binding affinity using SMM-align, a novel stabilization matrix alignment method. BMC Bioinformatics 8: 238.
10. Freeman, M. L., K. G. Lanzer, T. Cookenham, B. Peters, J. Sidney, T. T. Wu, R. Sun, D. L. Woodland, A. Sette, and M. A. Blackman. 2010. Two kinetic patterns of epitope-specific CD8 T-cell responses following murine gamma-herpesvirus 68 infection. J. Virol. 84: 2881-2892.
11. Winslow, G. M., A. D. Roberts, M. A. Blackman, and D. L. Woodland. 2003. Persistence and turnover of antigen-specific CD4 T cells during chronic tuberculosis infection in the mouse. J. Immunol. 170: 2046-2052.
12. Liu, L., E. J. Usherwood, M. A. Blackman, and D. L. Woodland. 1999. T-cell vaccination alters the course of murine herpesvirus 68 infection and the establishment of viral latency in mice. J. Virol. 73: 9849-9857.
13. Flaño, E., D. L. Woodland, M. A. Blackman, and P. C. Doherty. 2001. Analysis of virus-specific CD4(+) t cells during long-term gammaherpesvirus infection. J. Virol. 75: 7744-7748.
14. Virgin, H. W., IV, P. Latreille, P. Wamsley, K. Hallsworth, K. E. Weck, A. J. Dal Canto, and S. H. Speck. 1997. Complete sequence and genomic analysis of murine gammaherpesvirus 68. J. Virol. 71: 5894-5904.
15. Arens, R., P. Wang, J. Sidney, A. Loewendorf, A. Sette, S. P. Schoenberger, B. Peters, and C. A. Benedict. 2008. Cutting edge: murine cytomegalovirus induces a polyfunctional CD4 T cell response. J. Immunol. 180: 6472-6476.
16. Ebrahimi, B., B. M. Dutia, D. G. Brownstein, and A. A. Nash. 2001. Murine gammaherpesvirus-68 infection causes multi-organ fibrosis and alters leukocyte trafficking in interferon-gamma receptor knockout mice. Am. J. Pathol. 158: 2117-2125.
17. Long, H. M., A. M. Leese, O. L. Chagoury, S. R. Connerty, J. Quarcoopome, L. L. Quinn, C. Shannon-Lowe, and A. B. Rickinson. 2011. Cytotoxic CD4+ T cell responses to EBV contrast with CD8 responses in breadth of lytic cycle antigen choice and in lytic cycle recognition. J. Immunol. 187: 92-101.
18. Robey, R. C., D. Lagos, F. Gratrix, S. Henderson, N. C. Matthews, R. J. Vart, M. Bower, C. Boshoff, and F. M. Gotch. 2009. The CD8 and CD4 T-cell response against Kaposi's sarcoma-associated herpesvirus is skewed towards early and late lytic antigens. PLoS ONE 4: e5890.
19. Long, H. M., O. L. Chagoury, A. M. Leese, G. B. Ryan, E. James, L. T. Morton, R. J. Abbott, S. Sabbah, W. Kwok, and A. B. Rickinson. 2013. MHC II tetramers visualize human CD4+ T cell responses to Epstein-Barr virus infection and demonstrate atypical kinetics of the nuclear antigen EBNA1 response. J. Exp. Med. 210: 933-949.
20. Gredmark-Russ, S., E. J. Cheung, M. K. Isaacson, H. L. Ploegh, and G. M. Grotenbreg. 2008. The CD8 T-cell response against murine gamma-herpesvirus 68 is directed toward a broad repertoire of epitopes from both early and late antigens. J. Virol. 82: 12205-12212.
21. Liu, L., E. Flaño, E. J. Usherwood, S. Surman, M. A. Blackman, and D. L. Woodland. 1999. Lytic cycle T cell epitopes are expressed in two distinct phases during MHV-68 infection. J. Immunol. 163: 868-874.
22. Usherwood, E. J., D. J. Roy, K. Ward, S. L. Surman, B. M. Dutia, M. A. Blackman, J. P. Stewart, and D. L. Woodland. 2000. Control of gamma-herpesvirus latency by latent antigen-specific CD8(+) T cells. J. Exp. Med. 192: 943-952.
23. Virgin, H. W., IV, R. M. Presti, X. Y. Li, C. Liu, and S. H. Speck. 1999. Three distinct regions of the murine gammaherpesvirus 68 genome are transcriptionally active in latently infected mice. J. Virol. 73: 2321-2332.
24. Herskowitz, J. H., M. A. Jacoby, and S. H. Speck. 2005. The murine gamma-herpesvirus 68 M2 gene is required for efficient reactivation from latently infected B cells. [Published erratum appears in 2011 J. Virol. 85: 3041.] J. Virol. 79: 2261-2273.
25. Jacoby, M. A., H. W. Virgin, IV, and S. H. Speck. 2002. Disruption of the M2 gene of murine gammaherpesvirus 68 alters splenic latency following intranasal, but not intraperitoneal, inoculation. J. Virol. 76: 1790-1801.
26. Macrae, A. I., E. J. Usherwood, S. M. Husain, E. Flaño, I. J. Kim, D. L. Woodland, A. A. Nash, M. A. Blackman, J. T. Sample, and J. P. Stewart. 2003. Murid herpesvirus 4 strain 68 M2 protein is a B-cell-associated antigen important for latency but not lymphocytosis. J. Virol. 77: 9700-9709.
27. Christensen, J. P., R. D. Cardin, K. C. Branum, and P. C. Doherty. 1999. CD4(+) T cell-mediated control of a gamma-herpesvirus in B cell-deficient mice is mediated by IFN-gamma. Proc. Natl. Acad. Sci. USA 96: 5135-5140.
28. Stuller, K. A., S. S. Cush, and E. Flaño. 2010. Persistent gamma-herpesvirus infection induces a CD4 T cell response containing functionally distinct effector populations. J. Immunol. 184: 3850-3856.
29. Brooks, D. G., L. Teyton, M. B. Oldstone, and D. B. McGavern. 2005. Intrinsic functional dysregulation of CD4 T cells occurs rapidly following persistent viral infection. J. Virol. 79: 10514-10527.
30. Darrah, P. A., D. T. Patel, P. M. De Luca, R.W. Lindsay, D. F. Davey, B. J. Flynn, S. T. Hoff, P. Andersen, S. G. Reed, S. L. Morris, et al. 2007. Multifunctional TH1 cells define a correlate of vaccine-mediated protection against Leishmania major. Nat. Med. 13: 843-850.
31. Stuller, K. A., and E. Flaño. 2009. CD4 T cells mediate killing during persistent gammaherpesvirus 68 infection. J. Virol. 83: 4700-4703.
32. Betts, M. R., J. M. Brenchley, D. A. Price, S. C. De Rosa, D. C. Douek, M. Roederer, and R. A. Koup. 2003. Sensitive and viable identification of antigen-specific CD8+ T cells by a flow cytometric assay for degranulation. J. Immunol. Methods 281: 65-78.
33. Karrer, U., S. Sierro, M. Wagner, A. Oxenius, H. Hengel, U. H. Koszinowski, R. E. Phillips, and P. Klenerman. 2003. Memory inflation: continuous accumulation of antiviral CD8+ T cells over time. J. Immunol. 170: 2022-2029.
34. Freeman, M. L., C. E. Burkum, K. G. Lanzer, M. K. Jensen, M. Ahmed, E. J. Yager, E. Flaño, G. M. Winslow, D. L. Woodland, and M. A. Blackman. 2011. Cutting edge: activation of virus-specific CD4 T cells throughout γ-herpesvirus latency. J. Immunol. 187: 6180-6184.
35. Heller, K. N., C. Gurer, and C. Münz. 2006. Virus-specific CD4+ T cells: ready for direct attack. J. Exp. Med. 203: 805-808.
36. Robertson, K. A., E. J. Usherwood, and A. A. Nash. 2001. Regression of a murine gammaherpesvirus 68-positive b-cell lymphoma mediated by CD4 T lymphocytes. J. Virol. 75: 3480-3482.
37. Liang, X., R. L. Crepeau, W. Zhang, S. H. Speck, and E. J. Usherwood. 2013. CD4 and CD8 T cells directly recognize murine gammaherpesvirus 68-immortalized cells and prevent tumor outgrowth. J. Virol. 87: 6051-6054.
38. Smith, C. M., G. T. Rosa, J. S. May, N. J. Bennett, A. M. Mount, G. T. Belz, and P. G. Stevenson. 2006. CD4+ T cells specific for a model latency-associated antigen fail to control a gammaherpesvirus in vivo. Eur. J. Immunol. 36: 3186-3197.
39. Quezada, S. A., T. R. Simpson, K. S. Peggs, T. Merghoub, J. Vider, X. Fan, R. Blasberg, H. Yagita, P. Muranski, P. A. Antony, et al. 2010. Tumor-reactive CD4(+) T cells develop cytotoxic activity and eradicate large established melanoma after transfer into lymphopenic hosts. J. Exp. Med. 207: 637-650.
40. Xie, Y., A. Akpinarli, C. Maris, E. L. Hipkiss, M. Lane, E. K. Kwon, P. Muranski, N. P. Restifo, and P. A. Antony. 2010. Naive tumor-specific CD4(+) T cells differentiated in vivo eradicate established melanoma. J. Exp. Med. 207: 651-667.
41. Mackett, M., J. P. Stewart, S. de V Pepper, M. Chee, S. Efstathiou, A. A. Nash, and J. R. Arrand. 1997. Genetic content and preliminary transcriptional analysis of a representative region of murine gammaherpesvirus 68. J. Gen. Virol. 78: 1425-1433.
42. Ahn, J. W., K. L. Powell, P. Kellam, and D. G. Alber. 2002. Gammaherpesvirus lytic gene expression as characterized by DNA array. J. Virol. 76: 6244-6256.
43. Cheng, B. Y., J. Zhi, A. Santana, S. Khan, E. Salinas, J. C. Forrest, Y. Zheng, S. Jaggi, J. Leatherwood, and L. T. Krug. 2012. Tiled microarray identification of novel viral transcript structures and distinct transcriptional profiles during two modes of productive murine gammaherpesvirus 68 infection. J. Virol. 86: 4340-4357.